LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article: Generation of airway epithelial cell air-liquid interface cultures from human pluripotent stem cells

    Berical, Andrew / Beermann, Mary Lou / Suzuki, Shingo / LeSuer, Jake / Matte, Taylor / Davis, Brian / Kotton, Darrell / Hawkins, Finn

    Journal of visualized experiments. 2022 June 14, , no. 184

    2022  

    Abstract: Diseases of the conducting airway such as asthma, cystic fibrosis (CF), primary ciliary dyskinesia (PCD), and viral respiratory infections are major causes of morbidity and mortality worldwide. In vitro platforms using human bronchial epithelial cells ( ... ...

    Abstract Diseases of the conducting airway such as asthma, cystic fibrosis (CF), primary ciliary dyskinesia (PCD), and viral respiratory infections are major causes of morbidity and mortality worldwide. In vitro platforms using human bronchial epithelial cells (HBECs) have been instrumental to our understanding of the airway epithelium in health and disease. Access to HBECs from individuals with rare genetic diseases or rare mutations is a bottleneck in lung research. Induced pluripotent stem cells (iPSCs) are readily generated by "reprogramming" somatic cells and retain the unique genetic background of the individual donor. Recent advances allow for the directed differentiation of iPSCs to lung epithelial progenitor cells, alveolar type 2 cells, as well as the cells of the conducting airway epithelium via basal cells, the major airway stem cells. Here we outline a protocol for the maintenance and expansion of iPSC-derived airway basal cells (hereafter iBCs) as well as their trilineage differentiation in air-liquid interface (ALI) cultures. iBCs are maintained and expanded as epithelial spheres suspended in droplets of extracellular matrix cultured in a primary basal cell medium supplemented with inhibitors of TGF-ß and BMP signaling pathways. iBCs within these epithelial spheres express key basal markers TP63 and NGFR, can be purified by fluorescence activated cell sorting (FACS), and when plated on porous membranes in standard ALI culture conditions, differentiate into a functional airway epithelium. ALI cultures derived from healthy donors are composed of basal, secretory and multiciliated cells and demonstrate epithelial barrier integrity, motile cilia, and mucus secretion. Cultures derived from individuals with CF or PCD recapitulate the dysfunctional CFTR-mediated chloride transport or immotile cilia, the respective disease-causing epithelial defects. Here, we present a protocol for the generation of human cells that can be applied for modeling and understanding airway diseases.
    Keywords asthma ; chlorides ; cystic fibrosis ; dyskinesia ; epithelial cells ; epithelium ; extracellular matrix ; fluorescence ; genetic background ; humans ; liquid-air interface ; lungs ; morbidity ; mortality ; mucus ; secretion
    Language English
    Dates of publication 2022-0614
    Size p. e63882.
    Publishing place Journal of Visualized Experiments
    Document type Article
    ZDB-ID 2259946-0
    ISSN 1940-087X
    ISSN 1940-087X
    DOI 10.3791/63882
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Generation of Airway Epithelial Cell Air-Liquid Interface Cultures from Human Pluripotent Stem Cells.

    Berical, Andrew / Beermann, Mary Lou / Suzuki, Shingo / LeSuer, Jake / Matte, Taylor / Davis, Brian / Kotton, Darrell / Hawkins, Finn

    Journal of visualized experiments : JoVE

    2022  , Issue 184

    Abstract: Diseases of the conducting airway such as asthma, cystic fibrosis (CF), primary ciliary dyskinesia (PCD), and viral respiratory infections are major causes of morbidity and mortality worldwide. In vitro platforms using human bronchial epithelial cells ( ... ...

    Abstract Diseases of the conducting airway such as asthma, cystic fibrosis (CF), primary ciliary dyskinesia (PCD), and viral respiratory infections are major causes of morbidity and mortality worldwide. In vitro platforms using human bronchial epithelial cells (HBECs) have been instrumental to our understanding of the airway epithelium in health and disease. Access to HBECs from individuals with rare genetic diseases or rare mutations is a bottleneck in lung research. Induced pluripotent stem cells (iPSCs) are readily generated by "reprogramming" somatic cells and retain the unique genetic background of the individual donor. Recent advances allow for the directed differentiation of iPSCs to lung epithelial progenitor cells, alveolar type 2 cells, as well as the cells of the conducting airway epithelium via basal cells, the major airway stem cells. Here we outline a protocol for the maintenance and expansion of iPSC-derived airway basal cells (hereafter iBCs) as well as their trilineage differentiation in air-liquid interface (ALI) cultures. iBCs are maintained and expanded as epithelial spheres suspended in droplets of extracellular matrix cultured in a primary basal cell medium supplemented with inhibitors of TGF-ß and BMP signaling pathways. iBCs within these epithelial spheres express key basal markers TP63 and NGFR, can be purified by fluorescence activated cell sorting (FACS), and when plated on porous membranes in standard ALI culture conditions, differentiate into a functional airway epithelium. ALI cultures derived from healthy donors are composed of basal, secretory and multiciliated cells and demonstrate epithelial barrier integrity, motile cilia, and mucus secretion. Cultures derived from individuals with CF or PCD recapitulate the dysfunctional CFTR-mediated chloride transport or immotile cilia, the respective disease-causing epithelial defects. Here, we present a protocol for the generation of human cells that can be applied for modeling and understanding airway diseases.
    MeSH term(s) Cell Differentiation ; Cystic Fibrosis/metabolism ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Epithelial Cells ; Humans ; Lung/metabolism ; Pluripotent Stem Cells
    Chemical Substances Cystic Fibrosis Transmembrane Conductance Regulator (126880-72-6)
    Language English
    Publishing date 2022-06-14
    Publishing country United States
    Document type Journal Article ; Video-Audio Media ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2259946-0
    ISSN 1940-087X ; 1940-087X
    ISSN (online) 1940-087X
    ISSN 1940-087X
    DOI 10.3791/63882
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis.

    Berical, Andrew / Lee, Rhianna E / Randell, Scott H / Hawkins, Finn

    Frontiers in pharmacology

    2019  Volume 10, Page(s) 74

    Abstract: Mutations in the cystic fibrosis transmembrane conductance regulator ( ...

    Abstract Mutations in the cystic fibrosis transmembrane conductance regulator (
    Language English
    Publishing date 2019-02-08
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2019.00074
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Loss of an extensive ciliary connectome induces proteostasis and cell fate switching in a severe motile ciliopathy.

    Brody, Steven L / Pan, Jiehong / Huang, Tao / Xu, Jian / Xu, Huihui / Koenitizer, Jeffrey / Brennan, Steven K / Nanjundappa, Rashmi / Saba, Thomas G / Berical, Andrew / Hawkins, Finn J / Wang, Xiangli / Zhang, Rui / Mahjoub, Moe R / Horani, Amjad / Dutcher, Susan K

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Motile cilia have essential cellular functions in development, reproduction, and homeostasis. Genetic causes for motile ciliopathies have been identified, but the consequences on cellular functions beyond impaired motility remain unknown. Variants ... ...

    Abstract Motile cilia have essential cellular functions in development, reproduction, and homeostasis. Genetic causes for motile ciliopathies have been identified, but the consequences on cellular functions beyond impaired motility remain unknown. Variants in
    Language English
    Publishing date 2024-03-21
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.03.20.585965
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Pulmonology in Pregnancy.

    Abston, Eric D / Hon, Stephanie M / Berical, Andrew

    American journal of respiratory and critical care medicine

    2017  Volume 197, Issue 1, Page(s) 127–129

    MeSH term(s) Cardiology ; Female ; Heart Diseases ; Humans ; Hypertension, Pulmonary ; Pregnancy ; Pulmonary Medicine ; Registries
    Language English
    Publishing date 2017-11-20
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.201707-1436RR
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Airway stem cell reconstitution by the transplantation of primary or pluripotent stem cell-derived basal cells.

    Ma, Liang / Thapa, Bibek R / Le Suer, Jake A / Tilston-Lünel, Andrew / Herriges, Michael J / Berical, Andrew / Beermann, Mary Lou / Wang, Feiya / Bawa, Pushpinder S / Kohn, Anat / Ysasi, Alexandra B / Kiyokawa, Hirofumi / Matte, Taylor M / Randell, Scott H / Varelas, Xaralabos / Hawkins, Finn J / Kotton, Darrell N

    Cell stem cell

    2023  Volume 30, Issue 9, Page(s) 1199–1216.e7

    Abstract: Life-long reconstitution of a tissue's resident stem cell compartment with engrafted cells has the potential to durably replenish organ function. Here, we demonstrate the engraftment of the airway epithelial stem cell compartment via intra-airway ... ...

    Abstract Life-long reconstitution of a tissue's resident stem cell compartment with engrafted cells has the potential to durably replenish organ function. Here, we demonstrate the engraftment of the airway epithelial stem cell compartment via intra-airway transplantation of mouse or human primary and pluripotent stem cell (PSC)-derived airway basal cells (BCs). Murine primary or PSC-derived BCs transplanted into polidocanol-injured syngeneic recipients give rise for at least two years to progeny that stably display the morphologic, molecular, and functional phenotypes of airway epithelia. The engrafted basal-like cells retain extensive self-renewal potential, evident by the capacity to reconstitute the tracheal epithelium through seven generations of secondary transplantation. Using the same approach, human primary or PSC-derived BCs transplanted into NOD scid gamma (NSG) recipient mice similarly display multilineage airway epithelial differentiation in vivo. Our results may provide a step toward potential future syngeneic cell-based therapy for patients with diseases resulting from airway epithelial cell damage or dysfunction.
    MeSH term(s) Humans ; Animals ; Mice ; Pluripotent Stem Cells ; Cell- and Tissue-Based Therapy ; Epithelial Cells ; Epithelium ; Mice, Inbred NOD ; Mice, SCID
    Language English
    Publishing date 2023-08-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2375354-7
    ISSN 1875-9777 ; 1934-5909
    ISSN (online) 1875-9777
    ISSN 1934-5909
    DOI 10.1016/j.stem.2023.07.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Pneumococcal Vaccination Strategies. An Update and Perspective.

    Berical, Andrew C / Harris, Drew / Dela Cruz, Charles S / Possick, Jennifer D

    Annals of the American Thoracic Society

    2016  Volume 13, Issue 6, Page(s) 933–944

    Abstract: Streptococcus pneumoniae is an important global pathogen that causes a wide range of clinical disease in children and adults. Pneumococcal pneumonia is by far the common presentation of noninvasive and invasive pneumococcal disease and affects the young, ...

    Abstract Streptococcus pneumoniae is an important global pathogen that causes a wide range of clinical disease in children and adults. Pneumococcal pneumonia is by far the common presentation of noninvasive and invasive pneumococcal disease and affects the young, the elderly, and the immunocompromised disproportionately. Patients with chronic pulmonary diseases are also at higher risk for pneumococcal infections. Substantial progress over the century has been made in the understanding of pneumococcal immunobiology and the prevention of invasive pneumococcal disease through vaccination. Currently, two pneumococcal vaccines are available for individuals at risk of pneumococcal disease: the 23-valent pneumococcal polysaccharide vaccine (PPV23) and the 13-valent pneumococcal protein-conjugate vaccine (PCV13). The goal of pneumococcal vaccination is to stimulate effective antipneumococcal antibody and mucosal immunity response and immunological memory. Vaccination of infants and young children with pneumococcal conjugate vaccine has led to significant decrease in nasal carriage rates and pneumococcal disease in all age groups. Recent pneumococcal vaccine indication and schedule recommendations on the basis of age and risk factors are outlined in this Focused Review. As new pneumococcal vaccine recommendations are being followed, continued efforts are needed to address the vaccine efficacy in the waning immunity of the ever-aging population, the implementation of vaccines using two different vaccines under very specific schedules and their real world clinical and cost effectiveness, and the development of next generation pneumococcal vaccines.
    MeSH term(s) Cost-Benefit Analysis ; Humans ; Immunity, Herd ; Immunization Schedule ; Pneumococcal Vaccines/therapeutic use ; Pneumonia, Pneumococcal/epidemiology ; Pneumonia, Pneumococcal/prevention & control ; Randomized Controlled Trials as Topic ; Risk Factors ; Streptococcus pneumoniae ; Vaccines, Conjugate/therapeutic use
    Chemical Substances 13-valent pneumococcal vaccine ; 23-valent pneumococcal capsular polysaccharide vaccine ; Pneumococcal Vaccines ; Vaccines, Conjugate
    Language English
    Publishing date 2016-04-13
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2717461-X
    ISSN 2325-6621 ; 1943-5665 ; 2325-6621
    ISSN (online) 2325-6621 ; 1943-5665
    ISSN 2325-6621
    DOI 10.1513/AnnalsATS.201511-778FR
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells.

    Mithal, Aditya / Capilla, Amalia / Heinze, Dar / Berical, Andrew / Villacorta-Martin, Carlos / Vedaie, Marall / Jacob, Anjali / Abo, Kristine / Szymaniak, Aleksander / Peasley, Megan / Stuffer, Alexander / Mahoney, John / Kotton, Darrell N / Hawkins, Finn / Mostoslavsky, Gustavo

    Nature communications

    2020  Volume 11, Issue 1, Page(s) 215

    Abstract: Efficient generation of human induced pluripotent stem cell (hiPSC)-derived human intestinal organoids (HIOs) would facilitate the development of in vitro models for a variety of diseases that affect the gastrointestinal tract, such as inflammatory bowel ...

    Abstract Efficient generation of human induced pluripotent stem cell (hiPSC)-derived human intestinal organoids (HIOs) would facilitate the development of in vitro models for a variety of diseases that affect the gastrointestinal tract, such as inflammatory bowel disease or Cystic Fibrosis. Here, we report a directed differentiation protocol for the generation of mesenchyme-free HIOs that can be primed towards more colonic or proximal intestinal lineages in serum-free defined conditions. Using a CDX2
    MeSH term(s) CDX2 Transcription Factor/metabolism ; Cell Differentiation ; Cystic Fibrosis ; Epithelial Cells ; Gene Knock-In Techniques ; Genetic Vectors ; Humans ; Induced Pluripotent Stem Cells/metabolism ; Intestine, Small ; Intestines/physiology ; Mesoderm/metabolism ; Organoids/cytology ; Organoids/metabolism ; Thyroid Nuclear Factor 1/genetics
    Chemical Substances CDX2 Transcription Factor ; CDX2 protein, human ; NKX2-1 protein, human ; Thyroid Nuclear Factor 1
    Language English
    Publishing date 2020-01-10
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-019-13916-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial.

    Garcia, Michael A / Rampon, Garrett L / Doros, Gheorghe / Jia, Shijing / Jagan, Nikhil / Gillmeyer, Kari / Berical, Andrew / Hudspeth, James / Ieong, Michael / Modzelewski, Katherine L / Schechter-Perkins, Elissa M / Ross, Craig S / Rucci, Justin M / Simpson, Steven / Walkey, Allan J / Bosch, Nicholas A

    Annals of the American Thoracic Society

    2021  Volume 18, Issue 9, Page(s) 1560–1566

    Abstract: The unprecedented public health burdens of coronavirus disease (COVID-19) have intensified the urgency of identifying effective, low-cost treatments that limit the need for advanced life support measures and improve clinical outcomes. However, personal ... ...

    Abstract The unprecedented public health burdens of coronavirus disease (COVID-19) have intensified the urgency of identifying effective, low-cost treatments that limit the need for advanced life support measures and improve clinical outcomes. However, personal protective equipment and staffing shortages, disease virulence, and infectivity have created significant barriers to traditional clinical trial practices. We present the novel design of a pragmatic, adaptive, multicenter, international, prospective randomized controlled clinical trial evaluating the safety and effectiveness of awake prone positioning in spontaneously breathing patients with COVID-19 (APPEX-19 [Awake Prone Position for Early Hypoxemia in COVID-19]). Key innovations of this trial include
    MeSH term(s) Bayes Theorem ; COVID-19 ; Humans ; Hypoxia ; Multicenter Studies as Topic ; Prone Position ; Prospective Studies ; Randomized Controlled Trials as Topic ; SARS-CoV-2 ; Treatment Outcome ; Wakefulness
    Language English
    Publishing date 2021-03-01
    Publishing country United States
    Document type Clinical Trial Protocol ; Journal Article
    ZDB-ID 2717461-X
    ISSN 2325-6621 ; 1943-5665 ; 2325-6621
    ISSN (online) 2325-6621 ; 1943-5665
    ISSN 2325-6621
    DOI 10.1513/AnnalsATS.202009-1124SD
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A multimodal iPSC platform for cystic fibrosis drug testing.

    Berical, Andrew / Lee, Rhianna E / Lu, Junjie / Beermann, Mary Lou / Le Suer, Jake A / Mithal, Aditya / Thomas, Dylan / Ranallo, Nicole / Peasley, Megan / Stuffer, Alex / Bukis, Katherine / Seymour, Rebecca / Harrington, Jan / Coote, Kevin / Valley, Hillary / Hurley, Killian / McNally, Paul / Mostoslavsky, Gustavo / Mahoney, John /
    Randell, Scott H / Hawkins, Finn J

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 4270

    Abstract: Cystic fibrosis is a monogenic lung disease caused by dysfunction of the cystic fibrosis transmembrane conductance regulator anion channel, resulting in significant morbidity and mortality. The progress in elucidating the role of CFTR using established ... ...

    Abstract Cystic fibrosis is a monogenic lung disease caused by dysfunction of the cystic fibrosis transmembrane conductance regulator anion channel, resulting in significant morbidity and mortality. The progress in elucidating the role of CFTR using established animal and cell-based models led to the recent discovery of effective modulators for most individuals with CF. However, a subset of individuals with CF do not respond to these modulators and there is an urgent need to develop novel therapeutic strategies. In this study, we generate a panel of airway epithelial cells using induced pluripotent stem cells from individuals with common or rare CFTR variants representative of three distinct classes of CFTR dysfunction. To measure CFTR function we adapt two established in vitro assays for use in induced pluripotent stem cell-derived airway cells. In both a 3-D spheroid assay using forskolin-induced swelling as well as planar cultures composed of polarized mucociliary airway epithelial cells, we detect genotype-specific differences in CFTR baseline function and response to CFTR modulators. These results demonstrate the potential of the human induced pluripotent stem cell platform as a research tool to study CF and in particular accelerate therapeutic development for CF caused by rare variants.
    MeSH term(s) Animals ; Cystic Fibrosis/drug therapy ; Cystic Fibrosis/genetics ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Cystic Fibrosis Transmembrane Conductance Regulator/metabolism ; Epithelial Cells/metabolism ; Humans ; Induced Pluripotent Stem Cells/metabolism ; Ion Transport
    Chemical Substances Cystic Fibrosis Transmembrane Conductance Regulator (126880-72-6)
    Language English
    Publishing date 2022-07-29
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-31854-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top